CHEK | Check-Cap Ltd. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	1.7600 - 1.8300
52 Week Range	1.7600 - 4.63
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	2,448
Average Volume	10,627
Shares Outstanding	5,850,360
Market Cap	10,647,655
Sector	Healthcare
Industry	Medical - Diagnostics & Research
IPO Date	2015-03-04

Valuation
Profitability
Growth
Health
P/E Ratio	-0.61
Forward P/E Ratio	N/A
EPS	-3.00
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	85
Country	Israel
Website	CHEK

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

CHEK's peers: FONR, BNR, SERA, OLK, LMDX, GTH, PMD, DRIO, BDSX, ACRS, CSTL, PRE, STIM, MDXH, NOTV

*Chart delayed

Analyzing fundamentals for CHEK we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see CHEK Fundamentals page.

Watching at CHEK technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on CHEK Technicals page.